On 9 September 2026, JINTAI ENERGY H (02728.HK) announced that Mr. Han Jinfeng has resigned as Chairman of the Board and the Nomination Committee, remaining as executive director, while Ms. Bai Jie has been appointed Chairman of both, effective immediately.
On 8 September 2026, Smart Fish Holdings Limited (00139.HK) announced that its wholly-owned subsidiary would acquire a residential property at The Waterfront, Kowloon, Hong Kong for HKD 20 million, with the consideration satisfied by offsetting part of the outstanding loan owed by the borrower to the company's wholly-owned money lending subsidiary (approximately HKD 33.9 million before offset); the property is intended for staff quarters and the acquisition constitutes a discloseable transaction.
On 8 September 2026, Huajin International Holdings Limited (02738.HK) issued a voluntary announcement noting recent unusual price movements of its shares; following reasonable enquiries, the board confirmed it is unaware of any cause of the movements, of any disclosable information or inside information, and that the group's business operations remain normal.
On 8 September 2026, TYK Medicines, Inc. (02410.HK) announced in a voluntary announcement that chairman, executive director and president Dr. Wu Yusheng had recently increased his shareholding through open-market purchases funded by his own funds, with the total planned increase not expected to exceed HKD 2 million; Dr. Wu has committed that shares acquired through increases in the coming month will be voluntarily locked up for six months from purchase.
On 8 September 2026, Imagi International Holdings Limited (00585.HK) announced the appointment of Mr. Jin Mingyi as executive director, corporate compliance vice president and general counsel with immediate effect; Mr. Jin has over 20 years of legal experience and previously served as senior legal director of 360 Security Technology and vice president of Nenglian Group, with a monthly director's fee of HKD 133,334 under a three-year service contract.
On 8 September 2026, Home Control International Limited (01747.HK) issued a voluntary announcement providing follow-up information on the HKEX disciplinary action, reiterating that the sanctions apply only to the company and two former directors; it disclosed that the controlling shareholder changed from NHPEA IV to Meta-Wisdom Tech Limited in June 2025 and all current directors were appointed after the relevant events, and that the company has voluntarily engaged a compliance adviser to strengthen internal controls and compliance.
On 8 September 2026, Excelland Robotics (Wuxi) Co., Ltd. (03231.HK) published its allotment results, fixing the offer price at HKD 14.45 per share with trading to commence on 9 September 2026; the Hong Kong public offer was subscribed 140.02 times without triggering clawback, the international offering was subscribed 0.99 times, net proceeds were approximately HKD 576.6 million, and issued shares after listing total 416,368,421.
On 8 September 2026, HBM Holdings Limited (02142.HK) announced in a voluntary announcement that collaborator Windward Bio had reported positive interim results from the Phase II part of POLARIS-1 for anti-TSLP antibody HBM9378/WIN378 in asthma: at week 24, the placebo-adjusted mean increase in FEV1 reached up to 256 mL (p=0.033), with FeNO down 43% and EOS down 51%, and a half-life of up to 75 days supporting twice-yearly dosing; the Phase III part has been initiated, with POLARIS-2 planned for the first half of 2027.
On 8 September 2026, ChinaSoft International Limited (00354.HK) announced in a voluntary announcement that it had won the bid for the Pan-home Furnishing OpenHarmony AI Innovation Centre project under the Guangdong Industrial Robots and Smart Home Application Empowerment Centre, with a contract value of approximately RMB 35.5 million; leveraging its Xi'an OpenHarmony adaptation centre experience, the group will build big data, all-domain intelligent interconnection and digital intelligence empowerment platforms in Foshan to expand into edge intelligence and spatial intelligence.
On 8 September 2026, AMCO United Holding Limited (00630.HK) announced the disposal of 24,556,500 shares of BFB Health Limited (00205.HK) to BFB Group Limited for a total consideration of approximately HKD 10,559,000 (approximately HKD 0.43 per share), after which it holds no BFB Health shares; the disposal constitutes a discloseable transaction, with an expected gain of approximately HKD 6.4 million subject to audit, and proceeds to be used for working capital and other purposes.
On 8 September 2026, Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (06990.HK) announced in a voluntary announcement that collaborator Windward Bio had reported positive interim results from the Phase II part of POLARIS-1 for anti-TSLP antibody SKB378/WIN378 in asthma (147 patients enrolled): at week 24, the placebo-adjusted mean increase in FEV1 reached up to 256 mL (p=0.033), with FeNO down 43% and EOS down 51%, and a half-life of up to 75 days supporting twice-yearly dosing; the Phase III part has been initiated.
On 8 September 2026, Alebund Pharmaceuticals (Jiangsu) Limited (09637.HK) announced in a voluntary announcement that the US FDA had approved the IND application for AP308, a first-in-class engineered recombinant IgA protease, to initiate a first-in-human clinical trial in IgA nephropathy; AP308 is believed to be the first IgA protease-based IgAN candidate approved for clinical trials, and the company holds global rights to the drug.
On 8 September 2026, Delton Technology (Guangzhou) Inc. (01989.HK) announced that its RMB 96 million capital increase in wholly-owned subsidiary Huangshi Guanghe Precision Circuit Co., Ltd. using fund-raising proceeds had been completed, with the subsidiary's registered capital increased from RMB 780 million to RMB 876 million and a renewed business licence obtained.
On 8 September 2026, OOH Holdings Limited (08091.HK) announced that major shareholder Silver Pro Investments Limited had sold 93,960,000 shares (approximately 13.05%) to Mr. Leung Chun Wai, Mr. Yam Wai Shing and Mr. Yau Siu Yeung for a total consideration of HKD 2,818,800 (HKD 0.03 per share); after the sale Silver Pro holds no shares, while the three buyers hold approximately 8.47%, 2.62% and 4.28% respectively.
On 8 September 2026, China National Culture Group Limited (00745.HK) announced that its indirect wholly-owned subsidiary Chic Culture had entered into a non-legally binding MOU with FIREVERSE Ventures for proposed strategic cooperation covering an AI-generated music content platform, artist discovery and AI co-creation, and live concerts and performance businesses; commercial terms are to be negotiated and finalised within three months, and the MOU does not constitute a discloseable or connected transaction.
On 8 September 2026, DEEPZERO (02723.HK) and BIDU-W (09888.HK) were confirmed to qualify for Southbound trading under Stock Connect and meet the fast-addition criteria of the HKEX Tech 100 Index; the two stocks will be added to the HKEX Tech 100 Index and the HKEX Tech and US Tech 100 Index after the market close on 11 September 2026, with the changes effective 14 September 2026.
